The Democratic Republic of the Congo is utilising a combination of new and standard diagnostic tools to control an outbreak of Ebola virus in the country’s Province of Bas-Uele.

Following the report of outbreak, the Ministry of Health (MOH) and other partners such as World Health Organisation (WHO) have immediately deployed laboratory resources to allow rapid detection and response.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

A mobile field lab by the National Institute of Biomedical Research (INRB) was sent to the affected zone of Likati, to complement the testing facilities at the INRB in Kinshasa.

An intensified field alert and response system has been set up in Likati, to facilitate early identification of suspect Ebola cases in the affected zone, quickly analyse samples on site, as well as to follow up on new laboratory-confirmed cases and contacts.

"An intensified field alert and response system has been set up in Likati, to facilitate early identification of suspect Ebola cases in the affected zone."

At the INRB laboratory, technicians are using a technology called GeneXpert to test for the Zaire strain of Ebola within one hour, with help from USAID, WHO Canada, the Global Outbreak Alert and Response Network (GOARN) and the Emerging and Dangerous Pathogens Laboratory Network (EDPLN).

Originally developed to diagnose tuberculosis, GeneXpert can also be used to detect various pathogens such as in the case of HIV, malaria, STIs and Ebola.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Further testing to detect other Ebola strains and diseases such as viral haemorrhagic fevers is performed on samples that are found negative for the Zaire strain.

Other tests such as OraQuick, which can analyse blood or saliva samples within half an hour, are also being used.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact